Semi-Synthesis of New 1,2,3-Triazole Derivatives of 9-Bromonoscapine and their Anticancer Activities

被引:5
作者
Hasanpour, Zahra [1 ]
Salehi, Peyman [1 ]
Bararjanian, Morteza [1 ]
Esmaeili, Mohammad-Ali [2 ]
Alilou, Mostafa [3 ]
Mohebbi, Maryam [1 ]
机构
[1] Shahid Beheshti Univ, Med Plants & Drugs Res Inst, Dept Phytochem, Tehran, Iran
[2] Western Univ, Schulich Sch Med & Dent & Robarts Res Inst, London, ON, Canada
[3] Univ Innsbruck, Ctr Mol Biosci, Inst Pharm Pharmacognosy, A-6020 Innsbruck, Austria
来源
IRANIAN JOURNAL OF PHARMACEUTICAL RESEARCH | 2021年 / 20卷 / 02期
关键词
9-Bromonoscapine; Triazole; Anti-cancer; Click chemistry; Breast cancer; RATIONAL DESIGN; NOSCAPINE ANALOGS; CLICK CHEMISTRY; PERTURB MITOSIS; ANTIBACTERIAL; CYCLOADDITION; ELUCIDATION; NARCOTINE; AGENT;
D O I
10.22037/ijpr.2020.113213.14170
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Novel 1,2,3-triazole-tethered 9-bromonoscapine derivatives were synthesized by the propargylation of N-nornoscapine followed by Huisgen's 1,3-dipolar cycloaddition of the terminal alkynes with different azides. Cytotoxicity of the products was studied by MTT assay against the MCF-7 breast cancer cell line. Most of the compounds revealed a better cytotoxicity than N-nornoscapine and 9-bromonornoscapine as the parent compounds. Among the synthesized compounds, those with a hydroxylated aliphatic side chain (5p, 5q, and 5r) showed the highest activities (IC50s: 47.2, 37.9, and 32.3 mu g/mL, respectively). Molecular docking studies showed that these compounds also had the highest docking scores and effective interactions with binding sites equal to -8.074, -7.425 and -7.820 kcal/mol, respectively.
引用
收藏
页码:546 / 560
页数:15
相关论文
共 35 条
  • [1] Aggarwal S, 2002, HELV CHIM ACTA, V85, P2458, DOI 10.1002/1522-2675(200208)85:8<2458::AID-HLCA2458>3.0.CO
  • [2] 2-L
  • [3] Alijanvand SH, 2020, INT J BIOL MACROMOL
  • [4] ILLICIT HEROIN MANUFACTURING BY-PRODUCTS - CAPILLARY GAS-CHROMATOGRAPHIC DETERMINATION AND STRUCTURAL ELUCIDATION OF NARCOTINE-RELATED AND NORLAUDANOSINE-RELATED COMPOUNDS
    ALLEN, AC
    COOPER, DA
    MOORE, JM
    GLOGER, M
    NEUMANN, H
    [J]. ANALYTICAL CHEMISTRY, 1984, 56 (14) : 2940 - 2947
  • [5] Rational design of the microtubule-targeting anti-breast cancer drug EM015
    Aneja, R
    Lopus, M
    Zhou, J
    Vangapandu, SN
    Ghaleb, A
    Yao, J
    Nettles, JH
    Zhou, BF
    Gupta, M
    Panda, D
    Chandra, R
    Joshi, HC
    [J]. CANCER RESEARCH, 2006, 66 (07) : 3782 - 3791
  • [6] Synthesis of microtubule-interfering halogenated noscapine analogs that perturb mitosis in cancer cells followed by cell death
    Aneja, Ritu
    Vanyapandu, Surya N.
    Lopus, Manu
    Viswesarappa, Vijaya G.
    Dhiman, Neerupma
    Verma, Akhilesh
    Chandra, Ramesh
    Panda, Dulal
    Joshi, Harish C.
    [J]. BIOCHEMICAL PHARMACOLOGY, 2006, 72 (04) : 415 - 426
  • [7] Synthesis of Diheterocyclic Compounds Based on Triazolyl Methoxy Phenylquinazolines via a One-Pot Four-Component-Click Reaction
    Dabiri, Minoo
    Salehi, Peyman
    Bahramnejad, Mahboobeh
    Sherafat, Fatemeh
    [J]. JOURNAL OF COMBINATORIAL CHEMISTRY, 2010, 12 (05): : 638 - 642
  • [8] PHARMACOKINETIC PROPERTIES OF NOSCAPINE
    DAHLSTROM, B
    MELLSTRAND, T
    LOFDAHL, CG
    JOHANSSON, M
    [J]. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1982, 22 (06) : 535 - 539
  • [9] Progress Toward the Development of Noscapine and Derivatives as Anticancer Agents
    DeBono, Aaron
    Capuano, Ben
    Scammells, Peter J.
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 2015, 58 (15) : 5699 - 5727
  • [10] Synthesis and Biological Evaluation of N-Substituted Noscapine Analogues
    DeBono, Aaron J.
    Xie, Jin Han
    Ventura, Sabatino
    Pouton, Colin W.
    Capuano, Ben
    Scammells, Peter J.
    [J]. CHEMMEDCHEM, 2012, 7 (12) : 2122 - 2133